CrizotinibALK G1269A mutation leading to crizotinib resistance: case report

被引:0
作者
机构
关键词
D O I
10.1007/s40278-017-39031-8
中图分类号
学科分类号
摘要
引用
收藏
页码:100 / 100
相关论文
共 1 条
[1]  
Oya Y(2017)Clinical efficacy of alectinib in patients with ALK-rearranged non-small cell lung cancer after ceritinib failure. Anticancer Research 37 6477-6480